Shareholding disclosure

Newron Pharmaceuticals S.p.A.

Collectively declared rate

22.03%

Threshold

Crossed upwards

Timeline

Published

05.11.2015

Transaction

02.11.2015

Voting rights breakdown

Voting rights acquired22.03%
Voting rights sold0%
Below threshold0%

Declared beneficial owners · 2

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

TBFB300057

Beneficial owner

Investor AB

Declared address

Investor AB, 10332 Stockholm

Change to the composition of the group by an indirect sale resulting from an intra-group transfer within the Investor group of the shares in Duba from Investor to Patricia Industries II. For clarification,Investor remains the beneficial owner. As of the date of this notice, the Newron shares are held dIrectly by Zambon and Duba Zambon Company S.p.A. Via Lillo del Duca n. 10,20091 - Bresso (Milan), Italy, Registry of Companies of Milan n. 01690280159 ("Zambon") is an entily controlled at 85.92% by GEFIM. Duba AB, Arsenalsgatan No. 8 C, 103 32, Stockholm, Sweden, registered number 556593-5508 ( Duba ) is (as of the date of this notice, a wholly-owned direct subsidiary of Patricia Industries II AB, 103 32 Stockholm, Sweden, registered number 556619-6811 ( Patricia Industries II ). Patricia Industries II is a wholly-owned direct subsidiary of Investor. On 21 January 2013, Zambon and Duba entered into a shareholders agreement relating to their respective stakes in Newron.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open